TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/6/23 19:35 | 6/2/23 | ATHA | Athira Pharma, Inc. | Health | BioPrd | Biological Products, (No Diag | Moebius Hans | WA | O | Chief Me | M.d | 11 | 1.35 | 0 | 8 | 11 | 81 | D | |||||||||||||||
11/17/22 19:10 | 11/15/22 | ATHA | Athira Pharma, Inc. | Health | BioPrd | Biological Products, (No Diag | Moebius Hans | WA | O | Chief Me | P | 16 | 3.29 | 0 | 5 | 8 | 66 | D | |||||||||||||||
10/17/22 18:06 | 10/13/22 | ATHA | Athira Pharma, Inc. | Health | BioPrd | Biological Products, (No Diag | Moebius Hans | WA | O | Chief Me | M.d | 11 | 1.35 | 0 | 8 | 15 | 61 | D | |||||||||||||||
6/30/22 17:00 | 6/28/22 | ATHA | Athira Pharma, Inc. | Health | BioPrd | Biological Products, (No Diag | Moebius Hans | WA | O | Chief Me | P | 29 | 2.88 | 0 | 10 | 23 | 53 | D | |||||||||||||||
7/21/21 16:47 | 7/21/21 | ATHA | Athira Pharma, Inc. | Health | BioPrd | Biological Products, (No Diag | Moebius Hans | WA | O | Chief Me | M.d | 38 | 1.35 | 0 | 28 | 999% | 30 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |